125 related articles for article (PubMed ID: 33813046)
41. Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls.
Trotta A; Di Forti M; Mondelli V; Dazzan P; Pariante C; David A; Mulè A; Ferraro L; Formica I; Murray RM; Fisher HL
Schizophr Res; 2013 Oct; 150(1):169-75. PubMed ID: 23891482
[TBL] [Abstract][Full Text] [Related]
42. Heavy cannabis use prior psychosis in schizophrenia: clinical, cognitive and neurological evidences for a new endophenotype?
Mallet J; Ramoz N; Le Strat Y; Gorwood P; Dubertret C
Eur Arch Psychiatry Clin Neurosci; 2017 Oct; 267(7):629-638. PubMed ID: 28190094
[TBL] [Abstract][Full Text] [Related]
43. White Matter Neurometabolic Signatures Support the Deficit and Nondeficit Distinction in Antipsychotic-Naïve First-Episode Psychosis Patients.
Bryant JE; Lahti AC; Briend F; Kraguljac NV
Schizophr Bull; 2021 Jul; 47(4):1068-1076. PubMed ID: 33693906
[TBL] [Abstract][Full Text] [Related]
44. Impaired sensorimotor gating in schizophrenia with deficit and with nondeficit syndrome.
Ludewig K; Vollenweider FX
Swiss Med Wkly; 2002 Apr; 132(13-14):159-65. PubMed ID: 12070788
[TBL] [Abstract][Full Text] [Related]
45. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
Hambrecht M; Häfner H
Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
[TBL] [Abstract][Full Text] [Related]
46. Stability of the diagnosis of deficit syndrome in schizophrenia.
Amador XF; Kirkpatrick B; Buchanan RW; Carpenter WT; Marcinko L; Yale SA
Am J Psychiatry; 1999 Apr; 156(4):637-9. PubMed ID: 10200748
[TBL] [Abstract][Full Text] [Related]
47. Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia.
Kopelowicz A; Zarate R; Tripodis K; Gonzalez V; Mintz J
Am J Psychiatry; 2000 Jun; 157(6):987-93. PubMed ID: 10831481
[TBL] [Abstract][Full Text] [Related]
48. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task.
Lahti AC; Holcomb HH; Medoff DR; Weiler MA; Tamminga CA; Carpenter WT
Am J Psychiatry; 2001 Nov; 158(11):1797-808. PubMed ID: 11691685
[TBL] [Abstract][Full Text] [Related]
49. The history of childhood trauma among individuals with ultra high risk for psychosis is as common as among patients with first-episode schizophrenia.
Sahin S; Yüksel Ç; Güler J; Karadayı G; Akturan E; Göde E; Özhan AA; Üçok A
Early Interv Psychiatry; 2013 Nov; 7(4):414-20. PubMed ID: 23343404
[TBL] [Abstract][Full Text] [Related]
50. Inflammatory markers in antipsychotic-naïve patients with nonaffective psychosis and deficit vs. nondeficit features.
Garcia-Rizo C; Fernandez-Egea E; Oliveira C; Justicia A; Bernardo M; Kirkpatrick B
Psychiatry Res; 2012 Jul; 198(2):212-5. PubMed ID: 22405656
[TBL] [Abstract][Full Text] [Related]
51. Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria.
Vaiva G; Cottencin O; Llorca PM; Devos P; Dupont S; Mazas O; Rascle C; Thomas P; Steinling M; Goudemand M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):481-5. PubMed ID: 11999898
[TBL] [Abstract][Full Text] [Related]
52. [Specialised first-episode psychosis services: a systematic review of the literature].
Skalli L; Nicole L
Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
[TBL] [Abstract][Full Text] [Related]
53. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
54. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and subtype specific differences in regional pathology.
Turetsky BI; Colbath EA; Gur RE
Biol Psychiatry; 1998 Jan; 43(2):84-96. PubMed ID: 9474441
[TBL] [Abstract][Full Text] [Related]
55. Visual information-processing impairments in deficit and nondeficit schizophrenia.
Bustillo JR; Thaker G; Buchanan RW; Moran M; Kirkpatrick B; Carpenter WT
Am J Psychiatry; 1997 May; 154(5):647-54. PubMed ID: 9137120
[TBL] [Abstract][Full Text] [Related]
56. Structural abnormalities in deficit and nondeficit schizophrenia.
Buchanan RW; Breier A; Kirkpatrick B; Elkashef A; Munson RC; Gellad F; Carpenter WT
Am J Psychiatry; 1993 Jan; 150(1):59-65. PubMed ID: 8417581
[TBL] [Abstract][Full Text] [Related]
57. The psychiatric symptomatology of deficit schizophrenia: a meta-analysis.
Cohen AS; Brown LA; Minor KS
Schizophr Res; 2010 May; 118(1-3):122-7. PubMed ID: 19887305
[TBL] [Abstract][Full Text] [Related]
58. Behavioural dysregulation of decision-making in deficit but not nondeficit schizophrenia patients.
Ludewig K; Paulus MP; Vollenweider FX
Psychiatry Res; 2003 Aug; 119(3):293-306. PubMed ID: 12914900
[TBL] [Abstract][Full Text] [Related]
59. Comparison of efficacy of social skills training for deficit and nondeficit negative symptoms in schizophrenia.
Kopelowicz A; Liberman RP; Mintz J; Zarate R
Am J Psychiatry; 1997 Mar; 154(3):424-5. PubMed ID: 9054795
[TBL] [Abstract][Full Text] [Related]
60. Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia.
Kirkpatrick B; Messias NC; Conley RR; Roberts RC
J Nerv Ment Dis; 2003 Sep; 191(9):563-7. PubMed ID: 14504564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
